Subscribe   RSS Contact Us

Kamp Commentary: Pricing Issues Take Center Stage in D.C.

May 23, 2017 — By Coalition for Healthcare Communication Executive Director John Kamp Participants at last week’s Coalition for Healthcare ... read more

Califf Calls for Off-label Promotion Code of Ethics

May 18, 2017 – At this week’s information-packed Coalition for Healthcare Communication’s Rising Leaders Conference, keynote speaker and former FDA ... read more

The Marketing Implications of Tax Reform

By John Kamp, Coalition for Healthcare Communication Executive Director May 11, 2017 – Although no one seems to like the ... read more

Gottlieb Vote Headed to Full Senate

May 1, 2017 – Having cleared the Senate Committee on Health, Education, Labor and Pensions (HELP) with a 14-9 vote ... read more

What Medical Marketers Can Expect from President Trump, Republican-led Congress

April 24, 2017 – There is no doubt that the Trump administration is likely to change health policy, but the ... read more

Kamp: Three Ways Congress Could Suppress DTC or All Medical Marketing

Coalition Commentary by Executive Director John Kamp April 17, 2017 — Agencies, media and clients all need to watch closely ... read more

States Make Moves to Ease, Restrict Medical Communications

March 31, 2017 – With Congress in a seemingly permanent state of gridlock, individual states are taking actions that may ... read more

Previous Next

Coalition and Med Ad News Present Healthcare Podcasts

You can visit to download podcasts on healthcare issues by John Kamp, the Coalition”s Executive Director.

persuasive essay writing

The 1st is on the defeated but still looming ad tax bill. The 2nd is an overview and analysis of the “New FDA.”

Med Ad News plans to present 3 more podcasts in this series.bayer cipro prostatitis

Study Finds CME Funding Doesn’t Create Bias

A new study by 4 researchers from the Cleveland Clinic showed that industry support of continuing medical education created no bias among participants.

The study acknowledges the controversy surrounding CME funding, then explains how it tested for bias among its participants. It is important to note that no previously published studies have addressed this perceived bias.

Peter Pitts Tells Why FDA DDMAC Letter to Bauman Isn’t a First Amendment Issue

From :

Much brouhaha about the DDMAC letter sent to Dr. Leslie Bauman about her enthusiastic comments about a yet-to-be-approved anti wrinkle injectable.

At first blush, this seems like regulatory creep and cause for First Amendment agita. But it isn”t. This is not a case of the FDA trying to stifle unregulated speech by an individual without “interest.” Dr. Bauman is a clinical And if you need to relax and unwind a little, what can be better than playing a fun game, which will not set your bank account short? Here on Slotozilla, you can play free slot machines any time of day, with no breaks and no curfews. investigator for the product she”s been touting. That”s “interest” whether the trial sponsor paid her to do so or not. (In this instance, there was no “pay for play.”) In any case, it”s an unambiguous regulatory no-no.

descriptive essay

Your comments are welcome here.internet viagra pharmacy

MM&M Profiles Tom Sullivan, a Forceful Defender of CME

The February issue of MM&M magazine spotlights Policymed.com blogger Tom Sullivan.

personal essay definition

Read the articleviagra, candadian drugs